Promoting effects of sanguinarine on apoptotic gene expression in human neuroblastoma cells

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 21, 2014, Pages 9445-9451

  Cecen, Emre ^a   Altun, Zekiye ^b   Ercetin, Pinar ^b   Aktas, Safiye ^b   Olgun, Nur ^b  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Gene expression; Neuroblastoma; Sanguinarine

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; BCL2L2 PROTEIN, HUMAN; BENZOPHENANTHRIDINE DERIVATIVE; CISPLATIN; ISOQUINOLINE DERIVATIVE; MUSCLE PROTEIN; NOL3 PROTEIN, HUMAN; SANGUINARINE; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HUMAN; NEUROBLASTOMA; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BENZOPHENANTHRIDINES; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; GENE EXPRESSION; HUMANS; ISOQUINOLINES; MUSCLE PROTEINS; NEUROBLASTOMA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84918505772     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.21.9445     Document Type: Article

References (43)

1. Adhami VM, Aziz MH, Mukhtar H, Ahmad N (2003). Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. Clin Cancer Res, 9, 3176-82.
2. Adhami VM, Aziz MH, Reagan-Shaw SR, et al (2004). Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Mol Cancer Ther, 3, 933-40.
3. Ahmad N, Gupta S, Husain MM, Heiskanen KM, Mukhtar H (2000). Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin.Cancer Res, 6, 1524-8.
4. Ahsan H, Reagan-Shaw S, Breur J, Ahmad N (2007). Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins. Cancer Lett, 249, 198-208.
5. Brodeur GM, Hogarty MD, Mosse YPMJM (2011). Neuroblastoma. In 'Principles and Practice of Pediatric oncology'. (Eds Pizzo PA and Poplack DG) pp. 886-922. (Lippincot Williams & Wilkins: Philadelphia).
6. Burgeiro A, Bento AC, Gajate C, Oliveira PJ, Mollinedo F (2013). Rapid human melanoma cell death induced by sanguinarine through oxidative stress. Eur J Pharmacol, 705, 109-18.
7. Chan SL, Lee MC, Tan KO, et al (2003). Identification of chelerythrine as an inhibitor of BclXL function. J Biol Chem, 278, 20453-6.
8. Chaturvedi MM, Kumar A, Darnay BG, et al (1997). Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. J Biol Chem, 272, 3012934.
9. Choi WY, Jin CY, Han MH, et al (2009). Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3. Anticancer Res, 29, 4457-65.
10. Choi WY, Kim GY, Lee WH, Choi YH (2008). Sanguinarine, a benzophenanthridine alkaloid, induces apoptosis in MDA-MB-231 human breast carcinoma cells through a reactive oxygen species-mediated mitochondrial pathway. Chemotherapy, 54, 279-87.
11. Debiton E, Madelmont JC, Legault J, Barthomeuf C (2003). Sanguinarine-induced apoptosis is associated with an early and severe cellular glutathione depletion. Cancer Chemother Pharmacol, 51, 474-82.
12. Ding Z, Tang SC, Weerasinghe P, et al (2002). The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death. Biochem Pharmacol, 63, 1415-21.
13. Gao SL, Wang LZ, Liu HY, et al (2014). miR-200a inhibits tumor proliferation by targeting AP-2 gamma in neuroblastoma cells. Asian Pac J Cancer Prev, 15, 4671-6.
14. Godowski KC (1989). Antimicrobial action of sanguinarine. J Clin Dent, 1, 96-101.
15. Hammerova J, Uldrijan S, Taborska E, Slaninova I (2011). Benzo(c) phenanthridine alkaloids exhibit strong anti-proliferative activity in malignant melanoma cells regardless of their p53 status. J Dermatol Sci, 62, 22-35.
16. Han MH, Kim GY, Yoo YH, Choi YH (2013a). Sanguinarine induces apoptosis in human colorectal cancer HCT-116 cells through ROS-mediated Egr-1 activation and mitochondrial dysfunction. Toxicol Lett, 220, 157-66.
17. Han MH, Kim SO, Kim GY, et al (2007). Induction of apoptosis by sanguinarine in C6 rat glioblastoma cells is associated with the modulation of the Bcl-2 family and activation of caspases through downregulation of extracellular signal-regulated kinase and Akt. Anticancer Drugs, 18, 913-21.
18. Han MH, Park C, Jin CY, et al (2013b). Apoptosis induction of human bladder cancer cells by sanguinarine through reactive oxygen species-mediated up-regulation of early growth response gene-1. PLoS One, 8, 63425.
19. Han MH, Yoo YH, Choi YH (2008). Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation. Chemotherapy, 54, 157-65.
20. Holy J, Lamont G, Perkins E (2006). Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine. BMC Cell Biol, 7, 13.
21. Huh J, Liepins A, Zielonka J, et al (2006). Cyclooxygenase 2 rescues LNCaP prostate cancer cells from sanguinarine-induced apoptosis by a mechanism involving inhibition of nitric oxide synthase activity. Cancer Res, 66, 3726-36.
22. Hussain AR, Al-Jomah NA, Siraj AK, et al (2007). Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells. Cancer Res, 67, 3888-97.
23. Jang BC, Park JG, Song DK, et al (2009). Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion. Toxicol, 23, 281-87.
24. Kim S, Lee TJ, Leem J, et al (2008). Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP and synergy with TRAIL. J Cell Biochem, 104, 895-907.
25. Kuftinec MM, Mueller-Joseph LJ, Kopczyk RA (1990). Sanguinaria toothpaste and oral rinse regimen clinical efficacy in short-and long-term trials. J Can Dent Assoc, 56, 31-3.
26. Larsson DE, Wickstrom M, Hassan S, Oberg K, Granberg D (2010). The cytotoxic agents NSC-95397, brefeldin A, bortezomib and sanguinarine induce apoptosis in neuroendocrine tumors in vitro. Anticancer Res, 30, 149-56.
27. Laster LL, Lobene RR (1990). New perspectives on Sanguinaria clinicals: individual toothpaste and oral rinse testing. J Can Dent Assoc, 56, 19-30.
28. Lee JS, Jung WK, Jeong MH, Yoon TR, Kim HK (2012). Sanguinarine induces apoptosis of HT-29 human colon cancer cells via the regulation of Bax/Bcl-2 ratio and caspase-9-dependent pathway. Int J Toxicol, 31, 70-7.
29. Malikova J, Zdarilova A, Hlobilkova A (2006a). Effects of sanguinarine and chelerythrine on the cell cycle and apoptosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 150, 5-12.
30. Malikova J, Zdarilova A, Hlobilkova A, Ulrichova J (2006b). The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine. Cell Biol Toxicol, 22, 439-53.
31. Matkar SS, Wrischnik LA, Hellmann-Blumberg U (2008). Sanguinarine causes DNA damage and p53-independent cell death in human colon cancer cell lines. Chem Biol Interact, 172, 63-71.
32. Mehdiabadi GB, Arab E, Rafsanjani KA, Ansari S, Moinzadeh AM (2013). Neuroblastoma in Iran: an experience of 32 years at a referral childrens hospital. Asian Pac J Cancer Prev, 14, 2739-42.
33. Missaoui N, Khouzemi M, Landolsi H, et al (2011). Childhood cancer frequency in the center of Tunisia. Asian Pac J Cancer Prev, 12, 537-42.
34. National Cancer Institute (2014). Surveillance, Epidemiology and End Results Database. http://seer.cancer.gov/. .
35. Park H, Bergeron E, Senta H, et al (2010). Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways. Biochem Biophys Res Commun, 399, 446-51.
36. Pica F, Balestrieri E, Serafino A, et al (2012). Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer. Anticancer Drugs, 23, 32-42.
37. Reagan-Shaw S, Breur J, Ahmad N (2006). Enhancement of UVB radiation-mediated apoptosis by sanguinarine in HaCaT human immortalized keratinocytes. Mol Cancer Ther, 5, 418-29.
38. Serafim TL, Matos JA, Sardao VA, et al (2008). Sanguinarine cytotoxicity on mouse melanoma K1735-M2 cells-nuclear vs. mitochondrial effects. Biochem Pharmacol, 76, 1459-15.
39. Weerasinghe P, Hallock S, Liepins A (2001a). Bax, Bcl-2, and NF-kappaB expression in sanguinarine induced bimodal cell death. Exp Mol Pathol, 71, 89-98.
40. Weerasinghe P, Hallock S, Tang SC, Liepins A (2001b). Sanguinarine induces bimodal cell death in K562 but not in high Bcl-2-expressing JM1 cells. Pathol Res Pract, 197, 717-26.
41. Weerasinghe P, Hallock S, Tang SC, Liepins A (2001c). Role of Bcl-2 family proteins and caspase-3 in sanguinarine-induced bimodal cell death. Cell Biol Toxicol, 17, 371-81.
42. Wiangnon S, Veerakul G, Nuchprayoon I, et al (2011). Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group. Asian Pac J Cancer Prev, 12, 2215-20.
43. Zhang ZG, Li G, Feng DY, et al (2014). Overexpression of NDRG2 can inhibit neuroblastoma cell proliferation through negative regulation by CYR61. Asian Pac J Cancer Prev, 15, 239-44.